Pages that link to "Q37984197"
Jump to navigation
Jump to search
The following pages link to Inhibiting homologous recombination for cancer therapy (Q37984197):
Displaying 28 items.
- Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization (Q26771165) (← links)
- DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of Cancer (Q26776513) (← links)
- Pathway-specific engineered mouse allograft models functionally recapitulate human serous epithelial ovarian cancer (Q28538059) (← links)
- RAD50 targeting impairs DNA damage response and sensitizes human breast cancer cells to cisplatin therapy (Q33727876) (← links)
- Targeting DNA repair pathways for cancer treatment: what's new? (Q34015040) (← links)
- NEK8 regulates DNA damage-induced RAD51 foci formation and replication fork protection (Q36205224) (← links)
- R-loops and genomic instability in Bre1 (RNF20/40)-deficient cells (Q36235507) (← links)
- Triapine potentiates platinum-based combination therapy by disruption of homologous recombination repair (Q37174956) (← links)
- HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates (Q37378670) (← links)
- Radioprotection of normal tissue cells (Q38196712) (← links)
- Embracing synthetic lethality of novel anticancer therapies (Q38554530) (← links)
- Regulation of recombination and genomic maintenance (Q38559892) (← links)
- Molecular inhibitors of DNA repair: searching for the ultimate tumor killing weapon. (Q38573619) (← links)
- miR-15a/miR-16 down-regulates BMI1, impacting Ub-H2A mediated DNA repair and breast cancer cell sensitivity to doxorubicin (Q38706087) (← links)
- DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7. (Q38756630) (← links)
- RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies. (Q38801052) (← links)
- Rosiglitazone enhances radiosensitivity by inhibiting repair of DNA damage in cervical cancer cells. (Q38873958) (← links)
- Targeting DNA repair and replication stress in the treatment of ovarian cancer. (Q39393235) (← links)
- The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining (Q41656985) (← links)
- Dentofacial parameters explaining variability in retroclination of the maxillary central incisors (Q51919465) (← links)
- Use of the XRCC2 promoter for in vivo cancer diagnosis and therapy. (Q52651261) (← links)
- Synthetic lethal targeting of RNF20 through PARP1 silencing and inhibition. (Q52773665) (← links)
- Nuclear cGAS suppresses DNA repair and promotes tumorigenesis (Q57793642) (← links)
- Dynamin impacts homology-directed repair and breast cancer response to chemotherapy (Q58104057) (← links)
- On the Mechanism of Hyperthermia-Induced BRCA2 Protein Degradation (Q61816601) (← links)
- Build Your Own Microscope: Step-By-Step Guide for Building a Prism-Based TIRF Microscope. (Q64883202) (← links)
- Clinically Applicable Inhibitors Impacting Genome Stability (Q88661083) (← links)
- Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs (Q89167605) (← links)